Albaracin, Kurt Jan S.

HRN: 10-06-38  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2022
CEFUROXIME 1.5GM (VIAL)
07/26/2022
08/02/2022
IV
1.5g
Q8H
AP
Waiting Final Action 
07/26/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/26/2022
08/02/2022
IV
500mg
Q8H
AP
Waiting Final Action 
01/05/2024
CEFTRIAXONE 1G (VIAL)
01/05/2024
01/12/2024
IV
2 Grams
OD
T/C POST-OP ADHESIONS
Waiting Final Action 
01/05/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/05/2024
01/12/2024
IV
500mg
Q8H
T/C POST OP ADHESIONS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: